In vitro activity of the new oxazolidinone AZD2563 against enterococci

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 10, 2002, Pages 3273-3275

  Eliopoulos, G M ^a   Wennersten, C B ^a   Moellering Jr , R C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; OXAZOLIDINONE DERIVATIVE; POSIZOLID; STREPTOMYCIN; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; DRUG POTENCY; ENTEROCOCCUS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ACETAMIDES; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES;

EID: 0036783663     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.10.3273-3275.2002     Document Type: Article

References (5)

1. Oxazolidinones: A review
2. In vitro activities of new oxazolidinone antimicrobial agents against enterococci
3. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin
4. Vancomycin-resistant enterococci